Ganga Pharmaceuticals Ltd - Company Profile

It is a healthcare public limited company based in Palghar, Maharashtra, India, established in 1989.
1989 Palghar, Maharashtra, India Active
Last Updated:
Access Report
About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd, a active public limited company, was established on 11 September 1989 in Palghar, Maharashtra, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: L99999MH1989PLC053392. Registered under ROC Roc Mumbai. it is listed on BSE: 539680. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.91 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹2.88 Cr and a net worth of ₹5.45 Cr. Its leadership includes Sanjay Vyankatesh Kulkarni (Director), Priti Bhaiya (Company Secretary), Chetan Bhikhubhai Patel (Director). Past directors included Sanjay Vyankatesh Kulkarni, Harish Bhagwandas Talreja, Priti Bhaiya. It holds ₹2.18 Cr open charges and ₹12.26 Cr settled loans. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gangatat, Dhanvantri Marg,Gopcharpada, Virar (E), Palghar - 401305, Palghar, Maharashtra, 401305.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L99999MH1989PLC053392

  • Registration Number

    053392

  • Incorporation Date

    11 September 1989

  • Authorized Capital

    ₹7.50 Cr

  • Paid-Up Capital

    ₹5.91 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 539680)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 Cr
  • Paid Up Capital ₹ 5.91 Cr
  • Company Age 36 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.18 Cr
  • Satisfied Charges ₹ 12.26 Cr
  • Revenue Growth **** 4.98%
  • Profit Growth **** 3.74%
  • Ebitda **** -88.78%
  • Net Worth 0.73%
  • Total Assets -0.14%
Company report

Ganga Pharmaceuticals Ltd

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Ganga Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ganga Pharmaceuticals Ltd?
Current Directors
Name Designation Appointment Date Status
Sanjay Vyankatesh Kulkarni Director 01 Apr 2012 Current
Priti Bhaiya Company Secretary 01 Jul 2025 Current
Chetan Bhikhubhai Patel Director 17 May 2013 Current
Anagh Bharat Sharma Cfo 06 Sep 2018 Current
Bharat Brijmohan Sharma Managing Director 11 Sep 1989 Current
Srijna Sharma Whole-Time Director 01 Apr 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 25 Jul 2019 Past
Pramod Abcsdd Additional Director 15 Sep 2015 Past
Pramod Abcsdd Company Secretary 22 Apr 2025 Past
Pramod Abcsdd Company Secretary 15 Mar 2016 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ganga Pharmaceuticals.

Ganga Pharmaceuticals Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 4.98% increase. The company also saw a slight improvement in profitability, with a 3.74% increase in profit. The company's net worth moved up by a moderate rise of 0.73%.

Ganga Pharmaceuticals revenue growth over time
Ganga Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.98%
*******
*******
*******
*******
Revenue from Operations
*******
 3.91%
*******
*******
*******
*******
Total Assets
*******
 -0.14%
*******
*******
*******
*******
Profit or Loss
*******
 3.74%
*******
*******
*******
*******
Net Worth
*******
 0.73%
*******
*******
*******
*******
EBITDA
*******
 -88.78%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ganga Pharmaceuticals?

In 2023, Ganga Pharmaceuticals had a promoter holding of 66.71% and a public holding of 33.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹21,781,000.00

Satisfied Charges

₹122,561,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.18 Cr
Latest Charge Details
Date Lender Amount Status
14 Dec 2021 Others ₹3.45 M Open
29 Sep 2021 Others ₹0.80 M Open
18 Jul 2020 Others ₹2.00 M Open
09 Jul 2020 Others ₹1.00 M Open
25 Jul 2019 Others ₹1.45 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Ganga Pharmaceuticals?

Unlock and access historical data on people associated with Ganga Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ganga Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ganga Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ganga Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ganga Pharmaceuticals Ltd last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Priti Bhaiya was appointed as a Company Secretary was appointed as a Company Secretary on 01 Jul 2025 & has been associated with this company since 10 months 23 days . was completed.

  • Balance Sheet

    Progress on Ganga Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Munna Baijnath Chaurasia was appointed as a Director was appointed as a Director on 27 Mar 2025 & has been associated with this company since 1 year 1 month . was documented.

  • Director Appointment

    Aman Mukesh Chaudhari was appointed as a Director was appointed as a Director on 27 Mar 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100513449 was registered on 14 Dec 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ganga Pharmaceuticals Ltd?

The CIN of Ganga Pharmaceuticals Ltd is L99999MH1989PLC053392.

Where is Ganga Pharmaceuticals Ltd headquartered?

Ganga Pharmaceuticals Ltd is headquartered at Gangatat, Dhanvantri Marg,Gopcharpada, Virar (E), Palghar - 401305, Palghar, Maharashtra, 401305.

When was Ganga Pharmaceuticals Ltd incorporated?

Ganga Pharmaceuticals Ltd was incorporated on 11 September 1989.

Who are the current directors of Ganga Pharmaceuticals Ltd?

The current directors of Ganga Pharmaceuticals Ltd are

What is the primary industry of Ganga Pharmaceuticals Ltd?

The primary industry of Ganga Pharmaceuticals Ltd is Manufacturing.

Is Ganga Pharmaceuticals Ltd a listed company?

Ganga Pharmaceuticals Ltd is listed. It is listed on BSE: 539680.

What is the capital structure of Ganga Pharmaceuticals Ltd?

The authorized capital of Ganga Pharmaceuticals Ltd is ₹7.50 Cr, and the paid-up capital is ₹5.91 Cr.

What is the compliance status of Ganga Pharmaceuticals Ltd?

The compliance status of Ganga Pharmaceuticals Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available